WI
MRNA icon

Wafra Inc’s Moderna MRNA Stock Holding History

Wafra Inc’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-41,740
Closed -$6.41M – 67
2023
Q1 		$6.41M Sell
41,740
-52,253
-56% -$8.62M 0.23% 59
2022
Q4 		$16.9M Hold
93,993
– – 0.65% 52
2022
Q3 		$11.1M Hold
93,993
– – 0.44% 56
2022
Q2 		$13.4M Buy
93,993
+7,602
+9% +$1.09M 0.51% 52
2022
Q1 		$14.9M Buy
86,391
+57,415
+198% +$9.67M 0.51% 52
2021
Q4 		$7.36M Sell
28,976
-42,617
-60% -$12.5M 0.23% 61
2021
Q3 		$27.6M Buy
+71,593
New +$26.4M 1.01% 37

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Wafra Inc's MRNA Position: Q2 2023 in Review

Wafra Inc sold out of Moderna (MRNA) in Q2 2023, closing a stake of 41,740 shares — an estimated $6.41M sold.

Wafra Inc first reported a position in MRNA in Q3 2021 and held it in 7 quarters. The position peaked at $27.6M in Q3 2021. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • Wafra Inc reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • Wafra Inc sold 41,740 Moderna shares in Q2 2023, an estimated $6.41M.
  • Wafra Inc first reported a position in Moderna in Q3 2021 and held it in 7 quarters.
  • Wafra Inc's Moderna position peaked at $27.6M in Q3 2021.
  • 965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Wafra Inc's 13F filing for Q2 2023, filed 21 Jul 2023.